Alembic Pharma Q4 PAT seen up 7.4% to Rs 92.9 cr: ICICI Securities

ICICI Securities has come out with its fourth quarter (January-March) earnings estimates for the Healthcare sector. The brokerage house expects Alembic Pharma to report net profit at 92.9 crore up 7.4% quarter-on-quarter.

Net Sales are expected to increase by 2.6 percent Q-o-Q (up 26.3 percent Y-o-Y) to Rs 791.1 crore, according to ICICI Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 0.6 percent Q-o-Q (up 0.9 percent Y-o-Y) to Rs 144.5 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.